In search of a novel target - Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 11, 2011, Pages 2638-2645

  Riedl, Sabrina ^a   Rinner, Beate ^b   Asslaber, Martin ^b   Schaider, Helmut ^b   Walzer, Sonja ^b,c   Novak, Alexandra ^b   Lohner, Karl ^a   Zweytick, Dagmar ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer plasma membrane; Peptide target; Phosphatidylserine exposure; Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT; ONOSMA PANICULATUM EXTRACT; PHOSPHATIDYLSERINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SELECTION; CONTROLLED STUDY; DRUG TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; KIDNEY CANCER; MEDICINAL PLANT; MELANOMA; METASTASIS; ONOSMA PANICULATUM; PRIORITY JOURNAL; PROSTATE CANCER; RHABDOMYOSARCOMA; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH;

APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; PHOSPHATIDYLSERINES;

EID: 80255124055     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2011.07.026     Document Type: Article

References (45)

1. G. Morgan, R. Ward, and M. Barton The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies Clin. Oncol. (R. Coll. Radiol.) 16 2004 549 560 (Pubitemid 39517664)
2. E.M. Bevers, P. Comfurius, and R.F. Zwaal Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications Lupus 5 1996 480 487 (Pubitemid 26354072)
3. M. Seigneuret, and P.F. Devaux ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes Proc. Natl. Acad. Sci. U.S.A. 81 1984 3751 3755 (Pubitemid 14087796)
4. R.F. Zwaal, P. Comfurius, and E.M. Bevers Surface exposure of phosphatidylserine in pathological cells Cell Mol. Life Sci. 62 2005 971 988 (Pubitemid 40655614)
5. R.F. Zwaal, and A.J. Schroit Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 1997 1121 1132 (Pubitemid 27079974)
6. V.A. Fadok, D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J. Immunol. 148 1992 2207 2216
7. S. Martin, C.P. Reutelingsperger, A. McGahon, J. Rader, R. van Schie, D. La Face, and D.R. Green Early redistribution of plasma membrane phophatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Ab1 J. Exp. Med. 182 1995 1545 1556
8. P. Williamson, E.M. Bevers, E.F. Smeets, P. Comfurius, R.A. Schlegel, and R.F. Zwaal Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets Biochemistry 34 1995 10448 10455
9. J. Connor, C. Bucana, I.J. Fidler, and A.J. Schroit Differentiation- dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation Proc. Natl. Acad. Sci. U.S.A. 86 1989 3184 3188 (Pubitemid 19129581)
10. H. Schroder-Borm, R. Bakalova, and J. Andrä The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine FEBS Lett. 579 2005 6128 6134 (Pubitemid 41546259)
11. T. Utsugi, A.J. Schroit, J. Connor, C.D. Bucana, and I.J. Fidler Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes Cancer Res. 51 1991 3062 3066
12. H. Woehlecke, A. Pohl, N. Alder-Baerens, H. Lage, and A. Herrmann Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2) Biochem. J. 376 2003 489 495 (Pubitemid 38010534)
13. S. Ran, A. Downes, and P.E. Thorpe Increased exposure of anionic phospholipids on the surface of tumor blood vessels Cancer Res. 62 2002 6132 6140 (Pubitemid 35244462)
14. M. Cichorek, K. Kozlowska, J.M. Witkowski, and M. Zarzeczna Flow cytometric estimation of the plasma membrane diversity of transplantable melanomas, using annexin V Folia Histochem. Cytobiol. 38 2000 41 43 (Pubitemid 30063971)
15. N. Papo, D. Seger, A. Makovitzki, V. Kalchenko, Z. Eshhar, H. Degani, and Y. Shai Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide Cancer Res. 66 2006 5371 5378 (Pubitemid 43844963)
16. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89 (Pubitemid 28150594)
17. M.S. Soengas, P. Capodieci, D. Polsky, J. Mora, M. Esteller, X. Opitz-Araya, R. McCombie, J.G. Herman, W.L. Gerald, Y.A. Lazebnik, C. Cordon-Cardo, and S.W. Lowe Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Nature 409 2001 207 211 (Pubitemid 32144287)
18. T. Miyashita, and J.C. Reed Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line Blood 81 1993 151 157 (Pubitemid 23013689)
19. N. Papo, A. Braunstein, Z. Eshhar, and Y. Shai Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion Cancer Res. 64 2004 5779 5786 (Pubitemid 39095578)
20. N. Yang, W. Stensen, J.S. Svendsen, and O. Rekdal Enhanced antitumor activity and selectivity of lactoferrin-derived peptides J. Pept. Res. 60 2002 187 197 (Pubitemid 35155428)
21. J.L. Gifford, H.N. Hunter, and H.J. Vogel Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties Cell Mol. Life Sci. 62 2005 2588 2598 (Pubitemid 41721232)
22. K. Lohner, A. Latal, R.I. Lehrer, and T. Ganz Differential scanning microcalorimetry indicates that human defensin, HNP-2, interacts specifically with biomembrane mimetic systems Biochemistry 36 1997 1525 1531 (Pubitemid 27074977)
23. N. Papo, and Y. Shai Host defense peptides as new weapons in cancer treatment Cell Mol. Life Sci. 62 2005 784 790 (Pubitemid 40655628)
24. D.W. Hoskin, and A. Ramamoorthy Studies on anticancer activities of antimicrobial peptides Biochim. Biophys. Acta 1778 2008 357 375
25. H.J. Vogel, D.J. Schibli, W. Jing, E.M. Lohmeier-Vogel, R.F. Epand, and R.M. Epand Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides Biochem. Cell Biol. 80 2002 49 63 (Pubitemid 34194228)
26. S. Spiegl-Kreinecker, J. Buchroithner, L. Elbling, E. Steiner, G. Wurm, A. Bodenteich, J. Fischer, M. Micksche, and W. Berger Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes J. Neurooncol. 57 2002 27 36 (Pubitemid 34692611)
27. B. Rinner, N. Kretschmer, H. Knausz, A. Mayer, H. Boechzelt, X.J. Hao, G. Heubl, T. Efferth, H. Schaider, and R. Bauer A petrol ether extract of the roots of Onosma paniculatum induces cell death in a caspase dependent manner J. Ethnopharmacol. 129 2010 182 188
28. K. Satyamoorthy, E. DeJesus, A.J. Linnenbach, B. Kraj, D.L. Kornreich, S. Rendle, D.E. Elder, and M. Herlyn Melanoma cell lines from different stages of progression and their biological and molecular analyses Melanoma Res. 7 Suppl 2 1997 S35 S42
29. M. Nesbit, H. Schaider, T.H. Miller, and M. Herlyn Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells J. Immunol. 166 2001 6483 6490 (Pubitemid 32467185)
30. J. Skog, T. Wurdinger, S. van Rijn, D.H. Meijer, L. Gainche, M. Sena-Esteves, W.T. Curry Jr., B.S. Carter, A.M. Krichevsky, and X.O. Breakefield Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat. Cell Biol. 10 2008 1470 1476
31. H.H. Boersma, B.L. Kietselaer, L.M. Stolk, A. Bennaghmouch, L. Hofstra, J. Narula, G.A. Heidendal, and C.P. Reutelingsperger Past, present, and future of annexin A5: from protein discovery to clinical applications J. Nucl. Med. 46 2005 2035 2050 (Pubitemid 46657451)
32. R.M. Broekhuyse Phospholipids in tissues of the eye. I. Isolation, characterization and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids Biochim. Biophys Acta 152 1968 307 315
33. P. Comfurius, J.M. Senden, R.H. Tilly, A.J. Schroit, E.M. Bevers, and R.F. Zwaal Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase Biochim. Biophys. Acta 1026 2005 153 160
34. T. Wiedmer, S.J. Shattil, M. Cunningham, and P.J. Sims Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor Biochemistry 29 1990 623 632 (Pubitemid 20041941)
35. M. Belting, and A. Wittrup Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease J. Cell Biol. 183 2008 1187 1191
36. Y. Manavbasi, D. Zweytick, R. Willumeit, and K. Lohner Phosphatidylserine selective peptides as novel anti-cancer agents Biophys. J. 96 2009 157
37. S. Riedl, B. Rinner, S. Tumer, H. Schaider, K. Lohner, and D. Zweytick Targeting the cancer cell membrane specifically with human lactoferricin derivatives Ann. Oncol. 22 Suppl. 3 2011 33
38. N. Papo, D. Seger, A. Makovitzki, V. Kalchenko, Z. Eshhar, H. Degani, and Y. Shai Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide Cancer Res. 66 2006 5371 5378 (Pubitemid 43844963)
39. K. Lohner, and S.E. Blondelle Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics Comb. Chem. High Throughput Screen. 8 2005 241 256 (Pubitemid 40488604)
40. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395 (Pubitemid 34100944)
41. Y. Shai, and Z. Oren From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides Peptides 22 2001 1629 1641 (Pubitemid 32918242)
42. S.E. Blondelle, and K. Lohner Optimization and high-throughput screening of antimicrobial peptides Curr. Pharm. Des. 16 2010 3204 3211
43. K.J. Hallock, D.K. Lee, and A. Ramamoorthy MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain Biophys. J. 84 2005 3052 3060 (Pubitemid 36531755)
44. N. Papo, and Y. Shai New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells Biochemistry 42 2003 9346 9354 (Pubitemid 36959242)
45. L.T. Eliassen, G. Berge, B. Sveinbjornsson, J.S. Svendsen, L.H. Vorland, and O. Rekdal Evidence for a direct antitumor mechanism of action of bovine lactoferricin Anticancer. Res. 22 2002 2703 2710 (Pubitemid 36069301)